NEW YORK, July 19 (GenomeWeb News) - Enzo Biochem today said that a federal court issued a ruling supporting the company's claims that "hundreds" of products marketed by certain companies infringe eight of Enzo's patents.
The ruling allows Enzo to pursue patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences and Molecular Probes. It also enables Enzo to claim that the defendants breached their contractual obligations to Enzo.
The cases are pending in the US District Court for the Southern District of New York.
No additional information was provided.